Zobrazeno 1 - 10
of 2 862
pro vyhledávání: '"Guo Mei"'
Publikováno v:
In International Immunopharmacology 25 December 2024 143 Part 1
Autor:
Zhang, Na, Guo, Jianghong, Zhang, Mengya, Yu, Yingmei, Guo, Mei, Xu, Hao, Wang, Zhendong, Wu, Linliang, Wang, Xiaofeng, Jiang, Xiaoyan
Publikováno v:
In Geriatric Nursing November-December 2024 60:150-155
Autor:
Zhang, Qian, Zhang, Yuanlv, Li, Xiaoxue, Cao, Qingqing, Ma, Fang, Li, Yang, Xie, Delang, Ma, Haiyang, Zhang, Bingbing, Li, Xiaojun, Feng, Yuqin, Guo, Jiajun, Guo, Mei, Liu, Guishan
Publikováno v:
In International Journal of Biological Macromolecules November 2024 281 Part 1
Autor:
Zhang, Yuanlv, Li, Yang, Guo, Jiajun, Feng, Yuqin, Xie, Qiwen, Guo, Mei, Yin, Junjie, Liu, Guishan
Publikováno v:
In Food Chemistry 30 October 2024 456
Autor:
Ren, Yue, Wang, Yilin, Zhang, Yuxin, Yang, Zhongshuai, Ma, Zhiming, Chen, Jiaxin, Chen, Xintong, Qiu, Zecheng, Tian, Jing, Pu, Aofei, Yin, Junjie, Guo, Mei, Song, Yating, Guo, Jiajun, Feng, Yuqin, Liu, Guishan
Publikováno v:
In Trends in Food Science & Technology October 2024 152
Publikováno v:
In Pattern Recognition March 2025 159
Autor:
Wang, Yilin, Ren, Yue, Zhang, Yuxin, Yang, Zhongshuai, Ma, Zhiming, Chen, Jiaxin, Chen, Xintong, Qiu, Zecheng, Tian, Jing, Pu, Aofei, Yin, Junjie, Guo, Mei, Song, Yating, Guo, Jiajun, Feng, Yuqin, Liu, Guishan
Publikováno v:
In Trends in Food Science & Technology February 2025 156
Autor:
Qiu, Zecheng, Chen, Xintong, Xie, Delang, Ren, Yue, Wang, Yilin, Yang, Zhongshuai, Guo, Mei, Song, Yating, Guo, Jiajun, Feng, Yuqin, Kang, Ningbo, Liu, Guishan
Publikováno v:
In Trends in Food Science & Technology January 2025 155
Publikováno v:
In Journal of Food Composition and Analysis January 2025 137 Part A
Autor:
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 227-237 (2024)
Abstract Introduction Currently, the cause of psoriatic arthritis (PsA) is unknown, and the effectiveness of current drug treatments is unsatisfactory. In March 2019, the US Food and Drug Administration (FDA) approved risankizumab, a humanized immuno
Externí odkaz:
https://doaj.org/article/02e8c4b1e856444593e5ab8c9f52f166